ArticleAnnals of surgical oncology2026
Robotic-Modified Taj Mahal Hepatectomy for Type IV Hilar Cholangiocarcinoma.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION AND
objectivesCurative resection of type IV hilar cholangiocarcinoma typically requires trisectionectomy, a procedure associated with high morbidity. The Taj Mahal hepatectomy, involving resection of segment IVb, V, and the caudate lobe, offers a parenchyma-preserving alternative.
methodsPatients with type IV hilar cholangiocarcinoma without vascular involvement are suitable candidates. A 59-year-old male with jaundice and 1-month weight loss underwent sequential percutaneous transhepatic biliary drainage (segment III and right posterior ducts) for elevated bilirubin (>30 mg/dL). Key steps included hepatoduodenal lymphadenectomy, distal bile duct division with frozen section, caudate mobilization via a left-sided approach, indocyanine green-guided segment IV resection with en bloc caudate lobectomy, and three separate cholangiojejunostomies.
resultsOperative time was 560 minutes with 300 mL blood loss. The postoperative course was uneventful, and the patient was discharged on day 8. Histopathology showed T2 moderately differentiated adenocarcinoma with negative margins and 14 tumor-free lymph nodes. At 11-month follow-up, the patient remained disease free. Four patients underwent this procedure over 12 months.
conclusionRobotic-modified Taj Mahal hepatectomy is a safe, feasible, parenchyma-preserving option for selected patients with type IV hilar cholangiocarcinoma.
Indexed as
Identifiers
41922858What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.